Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 KRAS mutations and rectal cancer response to chemoradiation: are we closer to personalization of therapy?

× No keyword cloud information.

4 in total

Review 1. Germline and somatic genetic predictors of pathological response in neoadjuvant settings of rectal and esophageal cancers: systematic review and meta-analysis.

Authors: L E Salnikova; D S Kolobkov
Journal: Pharmacogenomics J Date: 2015-06-30 Impact factor: 3.550

2. Role of KRAS mutation as predictor of pathologic response after neoadjuvant chemoradiation therapy for rectal cancer.

Authors: Jacopo Martellucci; Giovanni Alemanno; Francesca Castiglione; Carlo Bergamini; Andrea Valeri
Journal: Updates Surg Date: 2015-02-22

3. Identification of Synergistic Drug Combinations to Target KRAS-Driven Chemoradioresistant Cancers Utilizing Tumoroid Models of Colorectal Adenocarcinoma and Recurrent Glioblastoma.

Authors: Kshama Gupta; Jeremy C Jones; Virginea De Araujo Farias; Yuri Mackeyev; Pankaj K Singh; Alfredo Quiñones-Hinojosa; Sunil Krishnan
Journal: Front Oncol Date: 2022-05-18 Impact factor: 5.738

4. KRAS Mutation Status Is Not a Predictor for Tumor Response and Survival in Rectal Cancer Patients Who Received Preoperative Radiotherapy With 5-Fluoropyrimidine Followed by Curative Surgery.

Authors: Jeong Won Lee; Jong Hoon Lee; Byoung Yong Shim; Sung Hwan Kim; Mi-Joo Chung; Bong-Hyeon Kye; Hyung Jin Kim; Hyeon Min Cho; Hong Seok Jang
Journal: Medicine (Baltimore) Date: 2015-08 Impact factor: 1.889

4 in total